// App-Quantinova.ai

4083 : The Role Of Splenectomy In The Treatment Of Myelofibrosis

Researchers

Presenter

  • Anait L. Melikyan

Principal Investigators

  • Alla M. Kovrigina

  • Manana A. Sokolova

  • Ludmila U. Kolosova

  • Maksim A. Silaev

  • Elena A. Gilyazitdinova

  • Irina N. Subortseva

  • Eduard G. Gemdjian

  • Suren R Karagulyan

  • Valeri G. Savchenko

Medical Centers

  • high dose chemotherapy and bone marrow transplantation, Hematological Scientific Center, Ministry of Health, Moscow, Russia

  • Outpatient department, National Hematology Research Center, Moscow, Russia

  • National Research Center for Hematology, Moscow, Russia

  • National Research Center for Hematology, Moscow, Russia

  • Outpatient department, National Hematology Research Center, Moscow, Russia

  • National Research Center for Hematology, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Portal Hypertension

  • Thrombocytopenia

  • Myelofibrosis

  • Hypertension

  • Venous thrombosis

  • Anemia

Biomarkers

  • Proteasome Subunit Beta 8

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved